Open Access. Powered by Scholars. Published by Universities.®

Oncology Commons

Open Access. Powered by Scholars. Published by Universities.®

Articles 1 - 6 of 6

Full-Text Articles in Oncology

Complementary Art Interventions For Children Coping With Cancer: An Integrative Literature Review, Brenda Pacheco Nov 2017

Complementary Art Interventions For Children Coping With Cancer: An Integrative Literature Review, Brenda Pacheco

Grace Peterson Nursing Research Colloquium

Background: Cancer can be a physically and emotionally damaging disease. While there are various conventional pediatric cancer treatments, complementary alternative medicine (CAM), specifically art interventions, may be helpful in the care of these patients.

Objective: The aims of this integrative review were; (1) determine if art interventions impact coping with cancer in a pediatric population, (2) determine if the duration of the art intervention influences the impact on coping.

Methods: Articles were found through the following databases: Cumulative Index of Nursing and Allied Health (CINAHL), PubMed, PsycInfo, and ProQuest Nursing & Allied Health. Key search terms used included cancer, neoplasms, …


Targeting Cancer Stem Cells In Recurrent Lung Cancer, Karen T. Udoh Nov 2017

Targeting Cancer Stem Cells In Recurrent Lung Cancer, Karen T. Udoh

Posters-at-the-Capitol

Lung cancer is the leading cause of cancer mortality in the world. Five-year survivability still remains dismal due to drug resistance. The development of drug resistance with cisplatin or platinum/taxane combination chemotherapies has led patients to suffer from recurrent lung cancer. These chemotherapy treatments target cancer cells but leave behind cancer stem cells. Cancer stem cells (CSCs) are stem-like tumor cells that have the potential to differentiate, self-renew, and proliferate. This allows the cancer to relapse even after initial elimination of the tumor. We hypothesize that Verrucarin J will inhibit cell proliferation in lung cancer cells and CSCs by inducing …


Parallelization Of A Three-Dimensional Full Multigrid Algorithm To Simulate Tumor Growth, Dylan Goodin, Chin F. Ng, Hermann B. Frieboes Oct 2017

Parallelization Of A Three-Dimensional Full Multigrid Algorithm To Simulate Tumor Growth, Dylan Goodin, Chin F. Ng, Hermann B. Frieboes

Commonwealth Computational Summit

We present the performance gains of an openMP implementation of a fully adaptive nonlinear full multigrid (FMG) algorithm to simulate three-dimensional multispecies desmoplastic tumor growth on computer systems of varying processing capabilities. The FMG algorithm is applied to solve a recently published thermodynamic mixture model that uses a diffuse interface approach with fourth-order reaction-advection-diffusion PDEs (Cahn-Hilliard-type equations) that are coupled, nonlinear, and numerically stiff. The model includes multiple cell species and extracellular matrix (ECM), with adhesive and elastic energy contributions in chemical potential terms, as well as including blood and lymphatic vessels represented as continuous vasculatures. Advection-reaction-diffusion PDEs are employed …


Cognitive Issues In Childhood Cancer Survivors And Related Parental Perceptions And Behaviors: An Integrative Review Of Literature, Brian Decant, Joseph Tariman Aug 2017

Cognitive Issues In Childhood Cancer Survivors And Related Parental Perceptions And Behaviors: An Integrative Review Of Literature, Brian Decant, Joseph Tariman

Grace Peterson Nursing Research Colloquium

Background: Survivorship of childhood cancer is often accompanied by neurocognitive late-effects (NCLE) related to the disease and/or it’s associated treatment regimes.

Objectives: The primary purpose of this integrative literature review was to examine NCLE in pediatric cancer survivors and identify parental perceptions and behaviors that correlated to cognitive dysfunction in their children.

Method: An integrative literature review was completed utilizing searches in PubMed, CINAHL Complete, and PsycINFO. Some search terms included “childhood cancer”, “survivor”, “cognition”, “cognitive disorder”, “neurocognitive”, “late-effects”, “child(ren)”, “parent(s)”, and “perception”.

Results: Analysis of ten predominant methods of neurocognitive evaluation yielded five major cognitive deficit measures in pediatric …


Mutations In Braf Are Associated With Higher Levels Of Immune Infiltrates In Microsatellite-Stable Colon Cancer, Jake Rubin, Eduard Porta Parto Apr 2017

Mutations In Braf Are Associated With Higher Levels Of Immune Infiltrates In Microsatellite-Stable Colon Cancer, Jake Rubin, Eduard Porta Parto

GW Research Days 2016 - 2020

While BRAF is among the most well-established oncogenes in human cancers, more recently it has garnered attention for its role in suppressing antitumor immunity, especially in melanoma. Because tumor-infiltrating lymphocyte (TIL) density is strongly prognostic in colorectal cancer (CRC)7, we decided to investigate the connection between TIL density and the BRAF-activating V600E mutation in CRC.

We used ESTIMATE to quantify immune infiltrate in samples from the TCGA colon adenocarcinoma (COAD) dataset (n = 216). This is an algorithm that uses the gene-expression signature of 141 immune-related genes to infer the presence of immune cells in the tumor infiltrate. …


Direct Measurement Of Supra-Physiological Levels Of Ascorbate In Plasma Using A Nanophotometer, Bailey Wetherell, Jordan W. Witmer, Brett A. Wagner, Juan Dub, Joseph J. Cullen, Garry R. Buettner Mar 2017

Direct Measurement Of Supra-Physiological Levels Of Ascorbate In Plasma Using A Nanophotometer, Bailey Wetherell, Jordan W. Witmer, Brett A. Wagner, Juan Dub, Joseph J. Cullen, Garry R. Buettner

Research in the Capitol

High dose intravenously administered vitamin C (ascorbate) is currently being tested in clinical trials as an adjuvant to current standard of care therapies in a variety of cancers. Intravenous infusion is used with a goal to achieve supraphysiological ascorbate concentrations in blood of at least 20 mM, 300 to 500 times normal healthy concentrations (0.04-0.08 mM). These trials need quick and easy access to information on the levels of ascorbate achieved in the blood to make clinical decisions. Previous methods that quantify ascorbate levels in blood require extensive preparation, time, and materials that may not always be present in clinical …